CRISPR/Cas system has become one of the most powerful techologies in biomedical research, and has showed great potentials in the gene related diseases. However, efficient delivery systems of CRISPR/Cas to target cells remains challenging. In recent years, nanoparticles have showned great potentials for the delivery of CRISPR/Cas systems. This paper mainly approaches the development and new strategies of CRISPR/Cas delivery systems, as well as their application in the clinical diseases. By summarizing the CRISPR/Cas systems delivery, new strategies are expected for the gene therapy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/cmdc.202100777 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!